DR. ZUBOWSKI REPORTS ON CHANGES IN APPLICATION OF BOTOX IS ON THE HORIZON

As an injectible, Botox®, has helped turn many a plastic surgery skeptic into a proponent. In my opinion, Botox® bears a lot of the credit for calling attention to how, with little fuss and minimal time spent in offices like the Robert Zubowski MD Center for Plastic and Reconstructive Surgery in Paramus, NJ, anyone can avail themselves of safe, effective anti-aging medical technology. Today, many folks who might not consider plastic surgery or are not quite ready for an invasive procedure, yet wish to realize some visual transformation, are choosing Botox® and other facial injectible fillers such as Radiesse®, Restyalene®, and Juvéderm®.

The next generation of cosmetic interventions could revolutionize our field, while reaching many people, who, for a variety of reasons, have refrained from trying aesthetic procedures altogether. One new product, for example, a needleless, topical botulinum toxin type-A wrinkle gel is now undergoing clinical trials with the ultimate goal of being approved by the U.S. Food and Drug Administration (FDA), to treat wrinkles at the corners of the eyes, commonly known as crow’s feet.

According to the American Society of Plastic Surgeons (ASPS), an initial study examined 270 patients with moderate to severe wrinkling around the eyes. The study concluded that the new botulinum toxin gel worked to improve crow’s feet for 89 percent of the study participants. If approved, the drug would be administered only in doctors’ offices.

As with all new protocols, this latest tool against facial aging would only be introduced into our practice at the Robert Zubowski MD Center for Plastic and Reconstructive Surgery after having been carefully evaluated by us for its safety and efficacy.  However, it seems to hold promise.

In the meantime, for more information on the numerous ways to help you realize your cosmetic enhancement goals, please contact Ann Carbone, our Practice Manager.

Leave a Reply

Your email address will not be published. Required fields are marked *

Any Questions?

Latest News